MedPath

osgemcitabine palabenamide

Generic Name
osgemcitabine palabenamide
Drug Type
Small Molecule
Chemical Formula
C25H27F2N4O8P
CAS Number
840506-29-8
Unique Ingredient Identifier
XCL1K2T28K

Overview

NUC-1031 is under investigation in clinical trial NCT03610100 (Acelarin First Line Randomised Pancreatic Study).

Background

NUC-1031 is under investigation in clinical trial NCT03610100 (Acelarin First Line Randomised Pancreatic Study).

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath